ArticleOncology letters2018

Loss of beclin 1 expression in ovarian cancer: A potential biomarker for predicting unfavorable outcomes.

Toshiko Minamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.